Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
41.47
-1.49 (-3.47%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Monopar Therapeutics Employees
As of December 31, 2024, Monopar Therapeutics had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 6 or 60.00% compared to the previous year.
Employees
16
Change (1Y)
6
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$974,151
Market Cap
253.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
MNPR News
- 24 days ago - Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments - GlobeNewsWire
- 3 months ago - Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - PRNewsWire
- 4 months ago - Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways - Seeking Alpha
- 4 months ago - Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants - GlobeNewsWire
- 4 months ago - Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu - GlobeNewsWire
- 5 months ago - Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 5 months ago - Monopar Therapeutics: Radiopharmaceuticals And Rare Disease Potential In Focus - Seeking Alpha
- 5 months ago - Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments - GlobeNewsWire